Analyst Consensus ?
ConsensusHold25 ratings
Bullish1248.0%
Neutral1248.0%
Bearish14.0%
Ameren Corporation · AEE · FY2024 Q2 · Calendar Q3 2024
Ameren Reaffirms Guidance as Grid Investment and Load Growth Build
The supplied analysis supports a constructive but conditional view: maintained guidance, infrastructure investment, and prospective data-center and industrial load growth support Ameren's trajectory, while regulatory, environmental, litigation, and project-execution risks remain material.
Reported After market closeNYSEUtilities
$28.28B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.97
Consensus $0.93
EPS surprise
+4.3%
Reported versus consensus
Reported revenue
$1.69B
Consensus $1.87B
Revenue surprise
-9.7%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+1.6%
Event window
SPY move
-1.9%
Same window
Abnormal move
+3.4%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
-0.0%
Up to 20 sessions
AEESPY benchmark
Ask FN2 about AEE FY2024 Q2
Transcript, numbers and history already loaded
Why did AEE rise 1.6% after beating EPS estimates in FY2024 Q2?What changed in AEE's guidance and outlook in FY2024 Q2?Give me the bull and bear case for AEE after FY2024 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, Ameren reported Q2 EPS of $0.97 and continued to maintain guidance. The current analysis adds progress on solar and natural-gas projects, a 250 MW data-center pipeline, 85 MW of additional industrial load under discussion, and full awards for MISO Tranche 1, while keeping attention on the Missouri IRP, Rush Island, and future MISO project execution.
Guidance delta
Management reaffirmed 2024 EPS guidance of $4.52-$4.72; the supplied analysis characterizes guidance sentiment as maintained.
Key takeaways
- Q2 EPS was $0.97, and management reaffirmed 2024 EPS guidance of $4.52-$4.72.
- Management highlighted solar and natural-gas project approvals, grid modernization, and a growing data-center and industrial load pipeline.
- Ameren secured all MISO Tranche 1 transmission projects and described a $55 billion investment plan through 2034.
- The main counterweights are regulatory uncertainty, environmental-rule changes, Rush Island litigation, and execution risk on major projects.
Management priorities
- Update and file the Ameren Missouri Integrated Resource Plan by February 2025.
- Advance the Castle Bluff 800 MW natural-gas plant toward commissioning by the end of 2027.
- Complete transmission extensions for the 250 MW data center by December 2025, with ramp-up through 2028.
- Pursue MISO Tranche 2.1 projects and prepare for Tranche 2.2 approvals in 2025.
Follow AEE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$104.32Current
$80Low
$108.69Average
$131High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keybanc | Overweight | Overweight | Maintain | Oct 13, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 30, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 25, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 18, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 17, 2026 |
| BTIG | Buy | Buy | Maintain | Aug 3, 2026 |
| Goldman Sachs | Hold | Hold | Maintain | Jul 31, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 16, 2026 |
| B of A Securities | Hold | Hold | Maintain | Jul 13, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Argus Research | Buy | Buy | Maintain | Mar 23, 2026 |
| UBS | Buy | Buy | Maintain | Feb 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 13, 2026 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 21, 2025 |
| Guggenheim | Neutral | Neutral | Maintain | Jul 7, 2023 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 16, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Sep 17, 2019 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 12, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Wunderlich Securities | Hold | Hold | Maintain | May 3, 2013 |
| Wunderlich | Hold | Hold | Maintain | May 3, 2013 |
| Edward Jones | Hold | Sell | Upgrade | Dec 24, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | May 8, 2012 |
| ISI Group | Hold | Hold | Maintain | Apr 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $104.32. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| KeyBanc | Sophie Karp | $116 | $103.24 | +11.2% | Oct 13, 2026 |
| Mizuho Securities | Anthony Crowdel | $113 | $100.25 | +8.3% | Sep 30, 2026 |
| Scotiabank | Ian Rapp | $104 | $99.39 | -0.3% | Sep 29, 2026 |
| RBC Capital | Stephen D\'Ambrisi | $107 | $98.46 | +2.6% | Sep 25, 2026 |
| Truist Financial | Analyst unavailable | $120 | $109.74 | +15.0% | Aug 17, 2026 |
| Mizuho Securities | Analyst unavailable | $124 | $109.61 | +18.9% | Aug 3, 2026 |
| BTIG | Analyst unavailable | $126 | $112.01 | +20.8% | Jul 23, 2026 |
| KeyBanc | Analyst unavailable | $122 | $112.01 | +16.9% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $118 | $111.36 | +13.1% | Jul 22, 2026 |
| Barclays | Nicholas Campanella | $117 | $112.54 | +12.2% | Jul 9, 2026 |
| Morgan Stanley | David Arcaro | $115 | $112.71 | +10.2% | Jun 24, 2026 |
| Morgan Stanley | Analyst unavailable | $110 | $109.74 | +5.4% | May 21, 2026 |
| Morgan Stanley | David Arcaro | $117 | $110.68 | +12.2% | Apr 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $120 | $111.27 | +15.0% | Apr 21, 2026 |
| Truist Financial | Richard Sunderland | $126 | $111.27 | +20.8% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $116 | $111.86 | +11.2% | Apr 15, 2026 |
| BTIG | Alex Kania | $131 | $114.32 | +25.6% | Apr 9, 2026 |
| Morgan Stanley | David Arcaro | $116 | $109.46 | +11.2% | Feb 20, 2026 |
| UBS | William Appicelli | $127 | $109.31 | +21.7% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $113 | $109.4 | +8.3% | Feb 13, 2026 |
| Mizuho Securities | Analyst unavailable | $117 | $109.34 | +12.2% | Feb 13, 2026 |
| BMO Capital | Analyst unavailable | $120 | $109.34 | +15.0% | Feb 13, 2026 |
| RBC Capital | Stephen D'Ambrisi | $116 | $101.85 | +11.2% | Jan 23, 2026 |
| Morgan Stanley | David Arcaro | $108 | $103.75 | +3.5% | Jan 21, 2026 |
| Wells Fargo | Analyst unavailable | $111 | $104 | +6.4% | Jan 20, 2026 |
| Barclays | Nicholas Campanella | $104 | $102.54 | -0.3% | Jan 15, 2026 |
| UBS | Analyst unavailable | $115 | $97.99 | +10.2% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $103 | $98.87 | -1.3% | Dec 16, 2025 |
| Wells Fargo | Analyst unavailable | $112 | $104.81 | +7.4% | Oct 27, 2025 |
| RBC Capital | Stephen D'Ambrisi | $119 | $104.81 | +14.1% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $114 | $104.18 | +9.3% | Oct 27, 2025 |
| Morgan Stanley | Analyst unavailable | $111 | $105.38 | +6.4% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $111 | $104.92 | +6.4% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $113 | $105.69 | +8.3% | Oct 21, 2025 |
| KeyBanc | Analyst unavailable | $109 | $104.23 | +4.5% | Oct 15, 2025 |
| Morgan Stanley | David Arcaro | $104 | $101.13 | -0.3% | Sep 25, 2025 |
| KeyBanc | Sophie Karp | $104 | $96.46 | -0.3% | Jul 16, 2025 |
| UBS | William Appicelli | $114 | $96.2 | +9.3% | Jul 11, 2025 |
| Goldman Sachs | Carly Davenport | $100 | $95.1 | -4.1% | Jun 25, 2025 |
| Morgan Stanley | David Arcaro | $102 | $95.4 | -2.2% | May 22, 2025 |
| KeyBanc | Sophie Karp | $103 | $95.42 | -1.3% | May 14, 2025 |
| Barclays | Analyst unavailable | $102 | $100 | -2.2% | Mar 4, 2025 |
| Jefferies | Julien Dumoulin-Smith | $97 | $83.62 | -7.0% | Sep 19, 2024 |
| Mizuho Securities | Anthony Crowdel | $89 | $83.99 | -14.7% | Sep 16, 2024 |
| BMO Capital | James Thalacker | $87 | $80.85 | -16.6% | Aug 6, 2024 |
| UBS | Daniel Ford | $87 | $74.82 | -16.6% | Jul 19, 2024 |
| BMO Capital | James Thalacker | $80 | $71.13 | -23.3% | Jun 21, 2024 |
| Barclays | Nicholas Campanella | $77 | $70.1 | -26.2% | May 30, 2024 |
| Goldman Sachs | Carly Davenport | $73 | $74.9 | -30.0% | May 16, 2024 |
| BMO Capital | James Thalacker | $81 | $73.85 | -22.4% | May 6, 2024 |
| Wells Fargo | Neil Kalton | $94 | $78.55 | -9.9% | Oct 19, 2023 |
| Barclays | Eric Beaumont | $80 | $77.43 | -23.3% | Sep 5, 2023 |
| KeyBanc | Sophie Karp | $90 | $83.36 | -13.7% | Jun 11, 2023 |
| Morgan Stanley | Analyst unavailable | $92 | $88.16 | -11.8% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $86 | $84.86 | -17.6% | Nov 11, 2022 |
| Mizuho Securities | Anthony Crowdell | $92 | $88.24 | -11.8% | Jul 8, 2022 |
| Argus Research | Analyst unavailable | $102 | $93.73 | -2.2% | Jun 3, 2022 |
| Argus Research | Analyst unavailable | $112 | $96.36 | +7.4% | May 26, 2022 |
| Mizuho Securities | Analyst unavailable | $98 | $95.8 | -6.1% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $104 | $95.92 | -0.3% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $101 | $97.75 | -3.2% | Apr 20, 2022 |
| Argus Research | Gary Hovis | $90 | $79.7 | -13.7% | Jun 24, 2021 |
| Bank of America Securities | Julien Dumoulin Smith | $89 | $81.8 | -14.7% | Jun 21, 2021 |
| Goldman Sachs | Insoo Kim | $90 | $84.49 | -13.7% | Jun 15, 2021 |
Track every rating change on AEE the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOperating across the United States, Ameren Corporation functions as a utility holding company. The enterprise organizes its operations into four primary divisions: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. Its fundamental business involves the rate-regulated production, transmission, and supply of electricity, in addition to the rate-regulated distribution and transmission of natural gas. Ameren generates power using a variety of sources, including coal, nuclear energy, and natural gas, supplemented by renewable alternatives such as hydroelectric, wind, methane gas, and solar. Its customer base encompasses residential homes, commercial businesses, and industrial operations. Established in 1881, Ameren Corporation is headquartered in St. Louis, Missouri.
Historical context
All AEE earningsLatest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the AEE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-12T21:30:46.725813+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-12T21:30:46.722578+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-12. For educational purposes only; not investment advice.